院际转运前已识别大缺血核心卒中:机械取栓与药物治疗比较的LASTE试验事后分析
该研究为LASTE随机对照试验的事后分析,纳入157例首诊于初级卒中中心、转运前影像即显示ASPECTS 0-5的前循环大血管闭塞急性缺血性卒中患者。取栓联合药物治疗较单纯药物治疗90天功能结局更优(广义优势比1.71,95%CI 1.21-2.41,p=0.002),支持对大缺血核心患者考虑院际转运行血管内治疗。
要点
- 首诊初级卒中中心、转运前ASPECTS 0-5的前循环大血管闭塞患者,取栓联合药物治疗功能结局优于单纯药物治疗。
- 取栓组90天死亡风险数值上更低(相对风险0.73,95%CI 0.50-1.05),症状性颅内出血数值上更常见(相对风险1.85,95%CI 0.64-5.26)。
- 疗效在不同ASPECTS分层间无异质性,支持包括ASPECTS 0-2在内的大缺血核心患者考虑院际转运行血管内治疗。
核心结论
- 对首诊于初级卒中中心、转运前已识别大缺血核心(ASPECTS 0-5)的前循环大血管闭塞急性缺血性卒中患者,取栓联合药物治疗较单纯药物治疗可改善90天功能结局。
研究设计与样本
- LASTE随机对照试验的事后分析,LASTE共纳入324例患者,本分析纳入157例首诊于初级卒中中心且转运前影像已显示ASPECTS 0-5者,其中80例单纯药物治疗、77例取栓联合药物治疗。
- LASTE纳入的是前循环大血管闭塞、大核心(ASPECTS 0-5)且在最后正常时间6.5小时内治疗的患者。
主要发现
- 取栓组90天功能结局优于单纯药物治疗组(广义优势比1.71,95%CI 1.21-2.41,p=0.002),且在不同ASPECTS分层间无异质性。
- 90天死亡率取栓组数值上更低(相对风险0.73,95%CI 0.50-1.05)。
- 症状性颅内出血取栓组数值上更常见(相对风险1.85,95%CI 0.64-5.26)。
- 本分析患者中位年龄73岁,美国国立卫生研究院卒中量表评分中位20分,最后正常至初级卒中中心影像时间中位120分钟,初级卒中中心影像ASPECTS 0-2者占56%、3-5者占44%。
临床怎么用
- 对首诊于初级卒中中心、转运前影像已显示大缺血核心(包括ASPECTS 0-2)的前循环大血管闭塞患者,若能在早期时间窗内到达综合卒中中心,可考虑院际转运行血管内治疗。
局限性
- 本研究为LASTE试验的事后分析,纳入的是特定筛选人群,结果需结合整体临床情况解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study assessed the efficacy of thrombectomy in acute ischemic stroke because of large-vessel occlusion (AIS-LVO) initially admitted to primary stroke centers (PSC) and subsequently transferred to a comprehensive stroke center (CSC), with a large ischemic core identified before transfer. METHODS: We performed a post hoc analysis of the Large Stroke Therapy Evaluation (LASTE) randomized controlled trial, which compared medical management (MM) plus thrombectomy and MM alone in anterior circulation AIS-LVO patients with a large core (Alberta Stroke Program Early Computed Tomography Score [ASPECTS], 0-5) treated within 6.5 hours of last seen well. This analysis included patients whose baseline imaging was obtained at a PSC and already demonstrated an ASPECTS of 0 to 5, before inter-hospital transfer. The primary outcome was a 90-day functional outcome, assessed using the modified Rankin Scale (mRS). RESULTS: Among the 324 patients enrolled in LASTE, 157 were included in this analysis, 80 received MM alone, and 77 underwent thrombectomy plus MM. Median age was 73 years, National Institutes of Health Stroke Scale score was 20, last seen well-to-PSC imaging time 120 minutes and ASPECTS on PSC imaging was 0 to 2 in 56% and 3 to 5 in 44%. Thrombectomy resulted in better functional outcomes than MM alone (generalized odds ratio, 1.71; 95% confidence interval [CI], 1.21-2.41; p = 0.002), without heterogeneity across ASPECTS strata. Mortality at 90 days was numerically lower in the thrombectomy group (relative risk = 0.73; 95% CI = 0.50-1.05), whereas symptomatic intracranial hemorrhage was numerically more frequent (relative risk = 1.85; 95% CI = 0.64-5.26). INTERPRETATION: These findings support consideration of inter-hospital transfer for EVT in AIS-LVO patients with large ischemic cores (including ASPECT, 0-2) admitted to PSCs who can reach the CSC in the early time-window. ANN NEUROL 2026.
引用
- Seners P, Ter Schiphorst A, Labreuche J, et al. Mechanical Thrombectomy Versus Medical Management for Large Ischemic Core Stroke Identified before Inter-Hospital Transfer: A Post Hoc Analysis of the LASTE Trial. Ann Neurol. 2026. PMID: 42770646. doi:10.1002/ana.78363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。